Huiying Medical Secures Tens of Millions in Series A Funding from BlueRun Ventures to Advance Medical Imaging AI and Big Data

Recently, HY Medical officially launched its new Nova 3.0 Smart Imaging Cloud Platform. The platform supports high-concurrency access of 300 users per second on a single server, features end-to-end encrypted data processing, and partners with Symantec to ensure network data security. Meanwhile, HY Medical announced that it has secured tens of millions of RMB in Series A financing from BlueRun Ventures China.

■ BlueRun Ventures China Deeply Invests in Medical Big Data and Medical AI

BlueRun Ventures China is a top-tier global early-stage venture capital firm managing both USD and RMB funds. It consistently focuses on highly disruptive startup projects, with portfolio companies including Ganji.com, Meilishuo, Changba, and Qudian. In the field of innovative healthcare, BlueRun Ventures China has invested in companies such as Chunyu Doctor and Xingshulin. HY Medical represents BlueRun Ventures China’s first investment in the fields of medical big data and artificial intelligence in medicine, underscoring the firm’s strategic presence in this sector.

BlueRun Ventures China has consistently favored startups with the potential to transform industry chains and possess strong growth momentum, placing significant emphasis on the professionalism and complementary skills of founding teams. HY Medical is the first medical imaging company invested in by BlueRun Ventures.

According to Chai Xiangfei, Mr. Chen Weiguang, a partner at BlueRun Ventures China, paid close attention to the industrial transformation brought about by big data and artificial intelligence technologies during his interactions with HY Medical.

Chen Weiguang, Partner at BlueRun Ventures China, stated, “We have long been optimistic about the profound changes that big data and artificial intelligence are bringing to industries such as healthcare. We believe that medical big data and AI, with medical imaging as the entry point, may be the first to achieve breakthroughs in commercialization models.”

Ye Dan, Investment Director at BlueRun Ventures China, stated: “First, we believe that services centered around medical imaging represent a vast market. HY Medical’s world-class AI-based medical image recognition technology, combined with a platform of nearly 1,000 professional physicians, can help improve diagnostic quality at primary care hospitals and enhance patients’ healthcare experience. Second, the HY Medical team has many years of specialized experience in the field of medical imaging. Among the teams we have encountered in this sector, they demonstrate the deepest understanding of the essence of healthcare and place the greatest emphasis on ‘operations’ and ‘practical implementation.’ These strengths will help the existing healthcare system better serve patients.”

Regarding the entrepreneurial DNA of the startup team, Mr. Chen Weiguang places particular emphasis on HY Medical’s overall team in terms of their entrepreneurial passion, capability reserves, and their agile learning ability to continuously solve problems in complex environments.

Chai Xiangfei, the founder of HY Medical, completed his postdoctoral fellowship at Stanford University School of Medicine under the supervision of Professor Lei Xing, Director of the Division of Radiation Physics and Chief Expert in Medical Physics. Professor Lei Xing has made numerous breakthrough contributions in the fields of radiotherapy planning and image recognition. He is a candidate for membership in the U.S. National Academy of Sciences and maintains long-term industry-academia-research collaborations with Varian Medical Systems. During this period, Professor Lei Xing led Chai Xiangfei and the development team in building an imaging cloud platform and a radiotherapy cloud platform to facilitate remote collaboration and big data analytics.

More importantly, Chai Xiangfei has research and development experience in automatic segmentation and registration of brain MRI, as well as image-guided adaptive radiotherapy systems. In 2014, he founded Topray in the United States to establish a large medical imaging database and apply deep learning algorithms to imaging. During this period, he developed image recognition technology based on neural network deep learning methods and won first prize in the North American division of the Chunhui Cup Entrepreneurship Competition.

In addition, the founding team of HY Medical possesses a cross-disciplinary DNA, achieving complementarity within the entrepreneurial team. Another partner, Guo Na, brings extensive experience in implementing large-scale projects. She previously engaged in long-term, in-depth collaborations with international internet companies such as Microsoft, Amazon, Google, Apple, and Cisco, and successfully executed a series of major projects to introduce cloud computing services from the global IT industry into China. A graduate of Tsinghua University who studied abroad at the University of Melbourne on a government-sponsored scholarship, Guo Na has maintained a sustained focus on the healthcare sector, ensuring that the founding team benefits from a broad international perspective and advantages in cross-sector resources.

■ Digitalization, Intelligence, and Mobility: HY Medical’s Three-Pronged Approach to Addressing Industry Pain Points

As a technology innovation company, HY Medical initially entered the market through medical imaging, focusing on cloud-based imaging systems, image recognition, and intelligent diagnosis. By leveraging its SaaS-based imaging cloud platform and integrating machine vision, deep learning, and data mining technologies, the company enables efficient workflows for physicians and hospitals while delivering precise diagnoses for patients.

HY Medical has, from the outset, integrated the mature models of third-party imaging centers in the United States and Japan with China’s healthcare policies and current realities. By leveraging emerging technologies such as cloud computing and artificial intelligence alongside high-quality diagnostic services provided by China’s leading radiologists, HY Medical actively participates in the national tiered diagnosis and treatment system and multi-site practice initiatives, aligning with the broader trend encouraged by central and local governments to foster the development of medical big data and the artificial intelligence industry.

After a year of exploration and development, HY Medical has made in-depth efforts across the dimensions of technology, products, channels, and ecosystem. At the technological level, the inherent internet, big data, and artificial intelligence attributes of medical imaging have enabled a high degree of integration across mobility, digitalization, and intelligence.

HY Medical has collected millions of medical imaging datasets through research collaborations. By building human organ models and leveraging deep neural network technologies, the company has achieved high accuracy in lesion detection and pioneered the integration of automated diagnostic applications for chest and brain MRI into clinical workflows. Dr. Chai Xiangfei, Founder and CEO of HY Medical, holds degrees from Stanford University and the Netherlands Cancer Institute. Over the past decade, he has been deeply engaged in medical imaging, radiation therapy, and medical AI, consistently dedicated to integrating mature, cutting-edge medical technologies into practical healthcare processes and commercializing these technologies to create greater value and impact.

Chai Xiangfei stated that HY Medical will continue to invest heavily in enhancing the computational performance of its large-scale GPU clusters to accelerate algorithm parameter tuning and performance optimization. In the future, HY Medical plans to sequentially release automated detection features for conditions such as carotid artery stenosis, brain MRI abnormalities, esophageal cancer, and cerebral infarction. These advancements aim to make breakthrough contributions to improving the accuracy of imaging diagnoses and reducing misdiagnosis rates. Furthermore, they will more effectively integrate medical imaging with the diagnosis and treatment of cardiovascular diseases, tumors, and other conditions, thereby generating greater value.

Leveraging its international academic background, HY Medical effectively integrates the strengths of Stanford University, Harvard University, the Netherlands Cancer Institute, Tsinghua University, and Beihang University to build an interdisciplinary team of experts in medical image recognition, applied mathematics, and computer convolutional neural networks. Its marketing team comprises elites recruited from Ogilvy Consulting, Novartis, GE, Siemens, and Carestream, delivering high-quality, empathetic, and story-driven product experiences that ensure technology truly serves people while respecting their value and experience. HY Medical has established strategic partnerships with Taikang Life Insurance, Baidu Doctor, Intel, China Telecom, China Unicom, Alibaba Cloud, and Jointown Health.

VCBeat will continue to monitor HY Medical’s next market moves following its successful fundraising.